Tim Juergens
Angel Investor @ SeedLink Ventures
Barcelona, Spain
Tim Juergens is a Co-Founder & General Manager of SeedLink SL.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Tim Juergens invests in
Stages Tim Juergens invests in
Countries Tim Juergens invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Pre-Seed
- $269k–$1.2M
Investment Focus
Industry
- Health Care 4 (80%)
- Personal Health 2 (40%)
- Medical 1 (20%)
- mHealth 1 (20%)
- Diabetes 1 (20%)
Stage
- Pre-Seed 3 (60%)
- Seed 2 (40%)
Country
- Germany 3 (60%)
- Switzerland 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| OneTwenty is an early-stage health tech start-up that develops multiple Machine Learning based solutions for people with diabetes as well as Medtech companies for sensor optimization, biomarker prediction, glucoregulatory models, and iAGC (interoperable automated glycemic controller). Our solution demonstrates unprecedented precision in bloodglucose prediction 120 minutes in advance. OneTwenty revolutionizes the life of people with Type 1 diabetes. | Seed / Mar 01, 2025 | ||
| Precision care for genito-pelvic pain. | $269.3K / Pre-Seed / May 12, 2024 | ||
| OneTwenty is an early-stage health tech start-up that develops multiple Machine Learning based solutions for people with diabetes as well as Medtech companies for sensor optimization, biomarker prediction, glucoregulatory models, and iAGC (interoperable automated glycemic controller). Our solution demonstrates unprecedented precision in bloodglucose prediction 120 minutes in advance. OneTwenty revolutionizes the life of people with Type 1 diabetes. | Pre-Seed / Jan 19, 2024 | ||
| Skinuvita specializes in developing digital home treatment solutions for chronic autoimmune skin diseases such as psoriasis, atopic dermatitis, and vitiligo. Utilizing specific wavelengths of UV light (311nm) that have a calming effect on skin's immune cells responsible for inflammation, Skinuvita's approach to phototherapy aims toimprove the quality of life for patients. The company offers a patient app that guides users through therapy sessions and analyzes responses for dosage optimization, alongside tools for dermatologists to monitor treatment progress. This innovative approach allows for effective management of skin conditions from the comfort of one's home. | $1.2M / Pre-Seed / Apr 01, 2022 | ||
| XO-Life.com is an online destination center. That provides services includes digital treatment monitoring and patient feedback R&D, marketing and sales. That offers services for Patient Insights, information exchange between patients and pharma, treatments and indications. | $2.3M / Seed / Feb 16, 2022 |
Co-Investors
About SeedLink Ventures
SeedLink Ventures is a European Venture Capital firm investing in early stage digital health companies developing value based solutions
SeedLink Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ignasi Heras
Founding Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Tim Juergens invest in?
Tim Juergens invests primarily in Health Care, Personal Health and Medical startups, most often at Pre-Seed and Seed stage. Most of the 5 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Tim Juergens invest in?
Tim Juergens typically joins rounds of $269k–$1.2M at Pre-Seed. These are whole funding-round sizes, not Tim Juergens's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Tim Juergens took part in.
How do I contact Tim Juergens?
Public channels for Tim Juergens include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Tim Juergens last invest?
The most recent investment recorded for Tim Juergens closed in May 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
